Our Team

At Anthos Therapeutics, our team is passionately focused on achieving our mission: the development and commercialization of genetically and pharmacologically validated innovative therapies for high-risk cardiovascular and metabolic disease patient populations.

Our Team

At Anthos Therapeutics, our team is passionately focused on achieving our mission: the development and commercialization of genetically and pharmacologically validated innovative therapies for high-risk cardiovascular and metabolic disease patient populations.

Anthos Therapeutics is led by a world-class executive team highly experienced in the successful development of therapies for CVM disease.

John Glasspool, a former leader of Novartis’ cardiovascular franchise with 30 years of experience in the biopharmaceutical industry, is CEO of Anthos Therapeutics. Mr. Glasspool served as Global Head of Novartis’ Cardiovascular and Metabolic Diseases franchise.

Management Team

Dan Bloomfield, M.D, Chief Medical Officer

Dan Bloomfield, M.D

Chief Medical Officer
Mike Doremus, Head of Technical Operations

Mike Doremus

Head of Technical Operations
Debra Freedholm, VP Clinical Operations

Debra Freedholm

VP Clinical Operations
Jonathan Freeman, Ph.D, Co-Founder and Chief Operating Officer

Jonathan Freeman, Ph.D

Co-Founder and Chief Operating Officer
John Glasspool, CEO

John Glasspool

CEO
Lynn Mallett, VP Finance, Human Resources & Corporate Treasurer

Lynn Mallett

VP Finance, Human Resources & Corporate Treasurer
Nik Mehta, Ph.D, Head of Regulatory, Quality and Technical Operations

Nik Mehta, Ph.D

Head of Regulatory, Quality and Technical Operations
Janeen Salter, Director of Clinical Operations

Janeen Salter

Director of Clinical Operations
Jessica Patrick Seabrook, Office Operations & Events Manager

Jessica Patrick Seabrook

Office Operations & Events Manager
Alex Yi, M.D, Ph.D, Senior Director, Medical Affairs

Alex Yi, M.D, Ph.D

Senior Director, Medical Affairs
David McIntyre B.EC., LL.B., CPA, MBA, Chief Financial Officer

David McIntyre B.EC., LL.B., CPA, MBA

Chief Financial Officer

Consultants

Connie Cullen, PH.D, Founder and Principal, Apollo Biologics

Connie Cullen, PH.D

Founder and Principal, Apollo Biologics
Yasser Khder, M.D, PH.D, Founder & Senior Consultant at MYRA Life Science Services

Yasser Khder, M.D, PH.D

Founder & Senior Consultant at MYRA Life Science Services

Board of Directors

Scott Beardsley,

Scott Beardsley

Ari Brettman, M.D,

Ari Brettman, M.D

Shaun R. Coughlin, M.D, Ph.D,

Shaun R. Coughlin, M.D, Ph.D

Nicholas Galakatos, Ph.D,

Nicholas Galakatos, Ph.D

John Glasspool, CEO

John Glasspool

CEO
Greg Norden,

Greg Norden

Paris Panayiotopoulos,

Paris Panayiotopoulos

Richard Pasternak, M.D,

Richard Pasternak, M.D